Dr. Ramón Cacabelos is Professor of Genomic Medicine at Camilo José Cela University, Madrid, and President of the EuroEspes Biomedical Research Center, Corunna, Spain. He received his M.D. from Oviedo University, Ph.D. from Santiago University, and D.M.Sci. (Psychiatry) from Osaka University Medical School, Japan. After a decade at the Department of Psychiatry in Osaka, he returned to Spain and focused his research activity on the genomics and pharmacogenomics of neurodegenerative disorders. He has published over 600 papers and 24 books, and is Editor-in-Chief of the first World Guide for Drug Use and Pharmacogenomics and President of the World Association of Genomic Medicine.

Genomics, Pharmacogenomics, Genomic Medicine, Neurogenetics, Drug development for brain disorders, Neurodegeneration/Alzheimer’s disease, Cerebrovascular disorders, Nutrigenomics.

Norman Buroker was born in Portland, OR, USA in 1943. He received his Bachelors of Science in General Science with a major in Chemistry and minors in Biology and Mathematics from Mississippi State University, Starkville, MS in 1968. He worked two years with the U.S. Fish and Wildlife Service, Seattle, WA and then entered the University of Washington where he received a Master of Science (1975) and Doctorate of Philosophy (1978) in Fisheries with emphasis in Biochemistry and Genetics. He took a position with as a Research Associate at the Center for Environmental and Estuarine Studies, University of Maryland in 1979 and then was awarded a Busch Postdoctoral Fellowship in 1981 with Department of Biological Sciences, Rutgers University, NJ. In 1983, he made a career change into medicine and took a position as a Research Associate in the Department of Biochemistry, School of Medicine, Oregon Health Sciences University. In 1987, he took a position as a Research Scientist in the Department of Pediatrics, School of Medicine, University of Washington. In 2003, he moved to a Research Scientist position in the Department of Cardiology at Seattle Children’s Hospital and in 2009 he moved back to the Department of Pediatrics, University of Washington where he currently works as a Senior Research Scientist. He has extensive research experience in molecular and population genetics and has several manuscripts involving these disciplines covering a wide variety of fields. His work in cardiology focused on nuclear and mitochondrial receptors in the mammalian heart and their association with metabolic genes. The research involved identifying and characterizing the PPAR response elements in promoter regions of target genes. Since returning to Pediatrics his research has changed to identifying mutations in genes associated with lysosomal storage diseases in newborns. In addition his research has also been involved with genetic studies of Han and Tibetan Chinese in high altitude environments. Also, he has published a number of papers involving SNPs, transcriptional factor binding sites, linkage disequilibrium among genes associated with human disease. All publications can be found on his Research Gate page.

Human Evolution, Population Genetics, High Altitude, Transcription Factors, Gender and Science, Gender Studies, Metabolism, Evolutionary Biology, Human Genetics, Physiology, PCR, Medical Genetics, DNA

Dr. Javier Andreu-Perez (MEng, MSc, PhD) studied his MEng at the Camilo Jose Cela University of Madrid and his MSc at the University of Granada, Spain. He received his PhD in Intelligent Systems from the School of Computing and Communications at Lancaster University, United Kingdom. He is currently Research Associate at the Hamlyn Centre within the Department of Computing of Imperial College London, United Kingdom, and member of thegroup of Machine Learning in Health Informatics led by Professor Guang-Zhong Yang. His research has been funded by governmental and industrial organizations and has been published in several relevant journal articles and book chapters. Likewise, he has co-edited special issues and is participating in technical committees and editorials.

Biomedical engineering, bioinformatics, machine learning and artificial intelligenceapplied to health science, neuroscience and brain research.

Dr. Gjumrakch Aliev, MD, PhD, President “GALLY” International Biomedical Research Institute Inc., San Antonio, Texas, USA. He also hold appointment with the University of Atlanta, Atlanta, Georgia, USA as a Professor of Cardiovascular, Neuropathology, Gerontology, Health Science and Healthcare Administration and Leading Researcher with the Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, Russia. He received his MD in 1982, from the Baku Medical University (former USSR) with cum laude. Then he accomplished his PhD in Cardiovascular Diseases from the prestigious Russian Academy of the Medical Sciences, Moscow, Russia in 1988 with cum laude. He received postdoctoral training with Professor G. Burnstock in the University College of the London. He authored and coauthored more than 500 publications in the fields of neurodegenerative diseases research (Alzheimer disease), as well as cardio- and cerebrovascular disease, cancer, and electron microscopy. He is an outstanding teacher, scholar, and a renowned scientist in the area of cellular Molecular physiology, and cardiovascular, and neurodegeneration-mediated pathologies including Alzheimer disease (AD). He is nationally and internationally reputed in his area. Dr. Aliev’s accomplishments in the area of biochemistry and cellular biology have tremendous implications for drug design towards CNS Neurological Disorders, AD, cancer, and cardio- and cerebrovascular and neurodegeneration related pathologies. He is world-renowned expert in electron microscopy. His work has been published in numerous prestigious journals such as Nature Clinical Cardiology, J. Neuroscience, Circulation Research, New England Journal of Medicine, Blood, J. Cellular and Molecular Medicine, Atherosclerosis, CNS Neurological Disorders & Drug Targets, international J. Biochemistry and Cell Biology, Scientific Reports and many others which reflect his leading role in his research areas.

Genomics, Pharmacogenomics, Genomic Medicine, Neurogenetics, Drug development for brain disorders, Neurodegeneration/Alzheimer Disease, Cerebrovascular disorders, Nutrigenomics Oxidative Stress, Mitochondrial Genomics

Dr. Alexander Vaiserman was born in KIev, Ukraine, in 1957. He earned his MSc Degree in cytology and developmental biology from Kiev State University in 1984, and his DSc degrees in normal physiology from Institute of Gerontology (Kiev, Ukraine) in 1991 and 2004, respectively. Since 1978, he has had a permanent position in the Institute of Gerontology (Kiev, Ukraine). Since 2010 to present he is the head of the Laboratory of Epigenetics in the Institute of Gerontology (Kiev, Ukraine). He is the member of the Editorial Boards of the journals Biogerontology, Frontiers in Genetics of Aging and Gerontology & Geriatric Research.

Epigenetics, Epidemiology, Anti-aging medicine, Experimental gerontology

Dr. Juan C. Carril is Director of the Genomics and Pharmacogenomics Department at EuroEspes Biomedical Research Center, Institute of Medical Science and Genomic Medicine, Corunna, Spain. He received his PhD from Santiago de Compostela University in 2000 defending the thesis “Genetic structure and profile of the populations of the Iberian Peninsula by means of markers (STRs and SNPs) of the human Y-chromosome”. He is responsible for Clinical Genetics, Predictive Risk Genetics and Pharmacogenetic analysis. Regarding his research work, he is working on the search for genetic risk markers for cerebrovascular, neurodegenerative and cancer pathologies. He has published more than 40 scientific publications in the fields of Population Genetics, Forensic Genetics, Genetic Epidemiology and Pharmacogenetics, and over 40communications at national and international conferences.

Genomics, Pharmacogenomics, Genomic Medicine, Neurogenetics, Neurodegeneration/Alzheimer’s disease, Cerebrovascular disorders, Nutrigenomics

Dr. Oscar Teijido Hermida is the head of the Medical Epigenetics Department at EuroEspes Biomedical Research Center, Institute of Medical Science and Genomic Medicine, Corunna, Spain. He received his PhD in the University of Barcelona, Spain in 2007 with his Thesis titled: Biochemical characterization and location of the protein MLC1, involved in the Megalencephalic Leukoencephalopathy with Subcortical Cysts. During his scientific career in University of A Corunna (Spain), University of Barcelona (Spain), New York University (USA), and The National Institutes of Health (USA), Dr. Teijido achieved more than 20 scientific publications in the molecular genetics, biochemistry, and physiology fields and presented his work in more than 25 International Conferences and invited presentations.

Epigenomics Pharmacoepigenomics Neurodegenerative disorders Cerebro-vascular disorders Cardio-vascular disorders Cancer

Dr Jerzy Leszek is Professor of Psychiatry, Vice-Head of the Department of Psychiatry and Head of Alzheimer’s Disease Lab at the Medical University in Wroclaw ,Poland. He is author and co-author more than 280 papers (especially from old age psychiatry), some chapters to the books published in reputed Polish and international journals and serving as an editorial board member of several journals .He is Editor –in-Chief of Journal of Yoga and Physical Activity. He is Scientific Editor and co-author of first Polish academic handbook on Alzheimer’s disease and nine another academic handbooks from old age psychiatry(Polish and internationals) , member a lot of scientific associations e.g founder and president of Lower Silesian Association of Alzheimer’s Families, first of its kind in Poland ,President of the Scientific Council of Alzheimer’s Disease Center in Scinawa, near Wroclaw , Former President and founder of Polish Psychogeriatric Association, and Former Member of Board of Directions of International Psychogeriatric Association.

Neurodegeneration processes/Alzheimer’s disease, Therapy of dementia disorders in the light of new technologies: nanotechnology, proteomics, metabolomics, genomic medicine, personalized therapy, Molecular base of neurodegenerative disorders, Rehabilitation and physical activity in dementia disorders

Dr. Alejandro Romero is the Associate professor at the Department of Toxicology and Pharmacology, Complutense University of Madrid. He received his graduated and Ph.D. degree in Biological Sciences, obtaining the Outstanding Doctorate Award.In 2008, as a Postdoctoral Fellow at the Department of Pharmacology and Therapeutics, AutonomousUniversity of Madrid, he was involved in neuroprotection studies. Currently, His main research focused on molecular toxicology and neurotoxicity studies.He has related in 15 research projects, 89 communications in national and international Congress, and he has published 52 research articles included in SCI.

Neurotoxicology, Neuroprotection, Molecular toxicology, Toxicogenomics, Drug development for brain disorders, Neurodegeneration/Alzheimer’s disease, Cerebrovascular disorders.

Dr. Alexander Koliada was born in Kiev, Ukraine, in 1986. He received MSc Degree in genetics from Kiev State University in 2008, and finish his DSc education in genetics from Instiute of Gerontology (Kiev, Ukraine). Since 2010, he has had a permanent research position in the Laboratory of Epigenetics of Institute of Gerontology (Kiev, Ukraine).

Epigenetics, Genetics, Molecular biology, Pharmacogenetics, Nutrigenomics.

Dr. Carmen Vigo is a Ph.D. recipient in Biochemistry from the University of London, Royal College of Surgeons of England, and BS from the Universidad Complutense of Madrid, Spain. She did postdoctoral work in lipid metabolism at the University of British Columbia, Canada, and was later a professor at the University of South Florida, Medical School, where she taught the core course of Biochemistry to postgraduate students and conducted research in cholesterol metabolism. For the last twenty years she continued her research work in the biotech and pharmaceutical industry in California. Her research was focused mainly in Alzheimer, liver, and vascular diseases. She made presentations as guest speaker in numerous national and international conferences. She is the co-inventor of ten issued patents in Alzheimer’s disease and stroke and filed over fifteen others in a broad medical field. She is the author of over one hundred scientific papers published in top peered-reviewed journals, several book chapters, and the Editor-in-Chief and co-author of three CRC books in Membrane Lipid Oxidation. She is the founder of two companies in the Bay Area, California, Atlas Pharmaceuticals and Neurocal.

Alzheimer, Liver, and Vascular diseases.

Prof. Masatoshi Takeda, MD, PhD, was educated at Dartmouth College(BA), Osaka University Medical School (MD), and Osaka University Graduate School of Medicine (PhD). After a post-doc at University of Florida, and Baylor College of Medicine, he was appointed to the Chairman Professor of Psychiatry, Osaka University in 1996.　In March 2015, he retired from the chairman professor of psychiatry at Osaka University by age, and has become the President of Aino University. Prof. Takeda has been involved with basic and clinical psychiatry research based on his background of molecular genetics, cell biology, and proteomics elucidating the pathogenesis of Alzheimer’s disease, schizophrenia, depression and other major psychiatric disorders. He has published more than 400 papers in English, and more than 400 papers in Japanese. His research topics cover molecular pathogenesis of neurodegenerative dementia, biomarkers of Alzheimer disease, clinico-pathogenesis of mood disorders, endophenotypes of schizophrenia, molecular genetic research of psychiatric disorders, and cognitive impairment in psychiatric disorders. Prof. Takeda served the President of Japanese Society of Biological Psychiatry (2006-2013), and the President of International Psychogeriatric Association (2009-2011). Now he is the President of Japanese Society of Psychiatry and Neurology (2012-present), President of WFSBP (2015-present), and the Secretary for Scientific Meetings of WPA (2014-present).

His research topics cover molecular pathogenesis of neurodegenerative dementia, biomarkers of Alzheimer disease, clinico-pathogenesis of mood disorders, endophenotypes of schizophrenia, molecular genetic research of psychiatric disorders, and cognitive impairment in psychiatric disorders.

Dr. Andrius Baskys is a practicing gero-psychiatrist as well as neuroscientist, inventor and educator. He has over 30 years of experience in mental health care and research focusing on memory disorders, their diagnosis and treatment. He completed his psychiatry residency at the University of Toronto, Canada, clinical fellowship at McMaster University, Hamilton and post-doctoral training at the University of California San Francisco. Throughout his career he taught and conducted research as a faculty member at the University of Toronto, University of California Irvine, UCLA as well as a visiting Professor at the FMMU in Xi’an, China. Dr. Baskys published over 200 papers, presentations and reports and two textbooks on psychopharmacology.

His most recent research interests are pharmacogenomics, aging, vascular dementia and development of mobile device-powered tools for bringing pharmacogenomic information to clinical practice.

Professor Valery Benberin currently works as a Head of Medical Center of President’s Affairs Administration of the Republic of Kazakhstan. He is the President of Eurasian Association of Gerontology, Geriatrics and Anti-Aging Medicine as well as the President of Gerontology and Geriatrics Society of Kazakhstan. He received his MD from Almaty State Medical Institute (Kazakhstan) in 1978. Since then he worked as a cardiologist at the Kazakh Cardiology Research Institute. In 1988 he completed PhD in Moscow, Russia. He got his Doctor of Medical Sciences in 2005. He has been working at the Presidential Clinic for more than 20 years. He has published over 200 papers.

Anti-aging medicine, Personalized medicine , Genomic medicine, Pharmacogenomics, Metabolomics, Cardiology, Immunology, Gerontology and geriatrics.

Dr. Francesco Marotta, MD (1981) and Specialized in Gastroenterology (1986), was a Fellow in gastroenterology at Chicago University (1982) and Registrar in gastroenterology at University of Cape-Town, South Africa. He received a Japanese-spoken PhD at Hirosaki University, Japan (1990). Fellow of Japanese Ministry of Science at National Cancer Center, Tokyo. Molecular biology stage in UK and South-Korea. Hon. Research Professor at Dept of Nutrition, Texas W University, USA and Adjunt prof. in Gastroenterology at Nutrition dept, Sichuan University, China. Visiting prof. at major Asian universities. Has directed a research center in Japan and cooperated with (Nobel) Prof. Montagnier. Advisory member of the CLS, Nazarbayev University and for the Ministry of Science of Kazakhstan. Editor-board member of over 35 medical journals. Has received several international prizes (Genomic Pioneer-2009 and Thomas Edison Award-2014-shared, Japan Liver Foundation). Has co-edited a successful book on aging-intervention and book chapters on probiotics and vitamins. Co-founder of ReGenera Research Group working on models of preventive/regenerative medicine and applying this as CMO at Milano Medical – Gender Healthy Aging Unit, in Italy. He has published about 145 papers and presented over 430 communications.

Nutraceutics and Functional Genomics, Genomic Medicine-based healthy aging strategies, Gut Microbiota and metagenomics

Dr. Dmitry Goldgaber is Professor of Psychiatry and Molecular Biology at the Department of Psychiatry and Behavioral Science in School of Medicine at Stony Brook University in New York. He received his Master of Science in physics from Leningrad Polytechnic Institute. He received his Ph.D. and Doctor of Science in Molecular Biology from Moscow State University. After eight years at the National Institutes of Health in Bethesda, Maryland he joined the Department of Psychiatry at Stony Brook University and focused his research on Alzheimer's disease, Down syndrome, Creutzfeldt-Jakob and other neurodegenerative diseases. He has published over 90 papers.

Alzheimer's disease, Neurodegenerative disorders,Down syndrome, Neurogenetics, Genomics, Genomic Medicine

Dr. Yasuhiko Kubota is a Clinical Psychiatrist and an administration officer at the Seijin Medical Corporation, Japan. He received his M.D. from Tohoku University School of Medicineand Ph.D. in psychiatry from Tohoku University Graduate School of Medicine, Japan. He worked as an assistant professor at the Department of Psychiatry of Tohoku University Hospital(2001-2004), an adjunct researcher at the EuroEspes Biomedical Research Center(2002-2004), and an associate professor at the Camilo José Cela University(2003-2004).

Psychiatry, Psychopharmacology, Pharmacogenomics, Neurodevelopment, Schizophrenia, Bipolar disorder

I received a Bachelor's degree in Biochemistry and Biotechnology from India in 2002. I have gained a wide range of technical skills from a medical laboratory technician course. I completed MS in Applied Biology from University of Missouri – Rolla (Now, Missouri University of Science and Technology) in 2006. In 2015, I earned Bioinformatics certificate from University of Illinois at Chicago. My professional experience includes pharmacodynamics, pharmacokinetics and pharmacogenomics research in oncology, neuroscience and cardiology at University of Illinois at Chicago.

Pharmacogenomics, Personalized medicine, Genetics, Molecular biology, DNA, Genotype

Dr. Yoshinori Muto received a B.S. in Biology at Kochi University and an M.S. in Developmental Biology at Ehime University in Japan. He then obtained his Ph.D. in Biochemistry from Gifu University in 1985. While studying for his Ph.D., he investigated the signal transduction of Tetrahymena cells under the supervision of Professor Yoshinori Nozawa. Dr. Muto worked as an Assistant Professor at the Institute of Anaerobic Bacteriology, Gifu University (1986-1992) and as an Associate Professor at College of Medical Sciences, Gifu University (1992-2005).Dr. Muto is currently a Professor of Biochemistry at Department of Functional Bioscience, the Gifu University School of Medicine, and holds a joint appointment at United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University.

1. Molecular evolution of protein family 2. Comparative genomics of positively selected genes 3. Gene co-expression network and its evolution

Magellan GuewoFokeng is a degree holder from the University of Yaounde 1 where he did his higher studies. He is currently a graduate Assistant, Department of Biochemistry, at the University of Yaounde I; and research associate at the Biotechnology Centre (BTC), Nkolbisson, Yaoundé and also a member of (1) Laboratory of Molecuar Medicine and Metabolism (LMMM) led by Prof. Sobngwi E and Prof. Mbanya JC and (2) Laboratory of Public Health Research Biotechnology (LAPHER-Biotech) led by Prof. Mbacham FW. In these laboratories, he is responsible for the Molecular part and genetics risks of Type 2 diabetes and obesity. He as published in the last two (02) years (2015-2016) six (06) publications in this field including the first Systematic Review and Meta-Analysis on the genetic risk of type 2 diabetes in the populations of the African continent, and over seventeen (17) communications at the National and International conferences.

Genetics of type 2 diabetes and Obesity; Molecular Biology; DNA genotype; Pharmacogenomics; Personalized Medicine; Genomic Medicine.

Fish nutrition and Physiology, Molecular Biology, Evolutionary Biology, Endocrinology.

Prof/Dr Cheorl-Ho Kim has received his MS and PhD in The University of Tokyo during the period of 1985-1990. Currently, since 2006 he is a professor in Department of Biological Sciences, College of Science, Sungkyunkwan University, Korea. He has successfully completed his Administrative responsibilities as Genome Program Head, Korea Research Institute of Bioscience and Biotechnology on 1990-1996 and Chairman, Department of Biochemistry and Molecular Biology, COM, Dongguk University during 1996-2006. His research has included the moleculr biology of gene expression, Golgi glycosyltransferase, oncognenesis, cancer metastasis and angiogenesis. He has authored 362 research articles/books with H-index 37. He is a member of International Scientific Advisory Board Member, International Symposium for Glycosyltransferases (GlycoT 2006), IUBMB symposium, Tsukuba and International Symposium for Glycosyltransferases (GlycoT 2008), Emory University, GA, USA, International Biochemical and Molecular Engineering 2013, San Antonio, TX, USA, and 5th World Congress of Biotechnology 2014, Valencia, Spain. He was served as a Key Note Speaker of 5th WCB. Key Note Speaker and Organizing member of 2nd World Congress of Glycobiology, 2016 August 29-31. Atlanta, Georgia, USA.

Cancer biology, Angiogenesis, Leukemia, Gene expression and transcriptional regulation, Glycosyltransferase, Tumor associated carbohydrate antigen, Carbohydrate Vaccines, Cell cycle, apoptosis, carcinogenesis, oncogenic transformation, growth factor-receptor interaction; cell differentiation; carbohydrate antigen; cell adhesion and angiogenesis; signal transduction.

Hsih-Te Yang, Ph.D., graduated from National Yang-Ming University with a bachelor’s degree in Medical Technology and thereafter with a doctoral degree in Biochemistry and molecular biology. Through research fellow experiences in NIH and US FDA, he is currently an assistant professor at Institute of Medical Informatics, Department of Computer Science and information engineering, National Cheng Kung University (NCKU), and a visiting assistant professor at School of Medicine, Keio University, Japan. Prof. Yang has been leading an innovative lab and team by conducting the research of system medicine. Our goal is to computationally discover and develop novel therapeutics toward improving human health using modern state-of-the-art technologies as well as Biomedical “Big” data. From 2005 to 2011, his research interests involve the construction of mathematical models, and their application to biological data. He had been extensively trained in the techniques regarding bioinformatics and computational biology.

Translational Bioinformatics, Antibody Discovery, and Cancer Genomics.

Hassan Ashktorab is a Professor in the Departments of Medicine. He serves, or has served as the member of gastrointestinal working group in the Howard University Cancer Center, executive member of The Howard University Cancer Center, the Adjunct Professor at The Department of Genetics and Human Genetics and the director of Microarray facility at Howard University and the chair of college of medicine Research committee. He has been awarded several NIH grants including RO3, RO1 and DOD grants. He has awarded the outstanding Researcher in 2011 in Howard University college of Medicine. He is a member of PLoS One and Digestive Disease and Science editorial board and past editorial board of GUT. He has been member of different NIH study sections since 2002. He was awarded visiting professorship from Jiangsu University, China in 2015.

His research focus is on epigenetics, genetics and epidemiology of gastrointestinal cancers especially colon cancer including the molecular mechanisms governing cellular proliferation, influence during oncogenic transformation and tumorigenesis. Our long term goals include the identification and characterization of genetic (distinctive mutations) and epigenetic factors (such as DNA methylation and histone modifications) that play a central and direct role in the initiation and/or progression of human cancers, specifically gastric and colon cancer. This includes research on chromatin modification through methylation or acetylation of genes/histones that may play critical role in the regulation of transcription of many genes, leading to alteration of cell function and cell cycle. In addition, detection of DNA methylation biomarkers for both early detection and prognosis is part of our interests using Next Generation Sequencing. We have recently detected several epigenetic (hypermethylated) and genetic biomarkers (novel mutations) that are significantly in tumors from African Americans compared to Whites (highlighted in Cancer and PNAS 2015). My translational/clinical research focuses on the African-American population, investigating genomic instability and gene alteration in patients with adenoma and colorectal cancer. This is a critical step for the understanding of the onset of cancer progression in African Americans with the goal of tackling this disease disparity in this population.

I had worked as Senior Research Fellow at National Bureau of Agriculturally Important Microorganisms (NBAIM) on a Network Project entitled ”Application of Microorganisms in Agriculture and Allied Sectors (AMAAS)”, sub theme-“Microbial Diversity” with main emphasis on “Diversity analysis of thermophilic fungi”.

My research interests involve the role of gut microflora and neuro-inflammation in progression of Alzheimer’s disease (AD). My PhD. research project, focused on the study of therapeutic potential of some synthetic as well as herbal compounds against amyloid beta toxicity in AD using drosophila as a transgenic AD model. These studies led to the publication in esteemed peer-reviewed neuroscience journals. I also used some metal chelators (Copper chelator) to prevent copper mediated amyloid beta toxicity in drosophila model system. I am currently employed as a postdoctoral scholar at the University of Chicago. In this new role I currently focus on the role of microbial immune responses in AD pathogenesis. Using a highly collaborative research approach, involving principal investigators from over the USA, I have induced perturbations in the gut microbiome of AD transgenic mice and investigated alterations in innate immunity and amyloidosis. These ongoing studies will significantly impact the research field and continue to explore the largely unknown contribution of commensal microbes in health and disease. I have significant experience in animal work (establishing transgenic drosophila lines, handling of transgenic mice model, oral gavage and injection treatments, behavioural testing and analysis, anesthesia, cardiac perfusion) including other laboratory techniques like; Isolation of DNA and RNA, Electrophoresis (SDS-PAGE & Agarose), Western Blotting, Screening of Microbes from Different Samples, PCR/RT-PCR, immunohistochemistry and Immunofluorescence. UV-Vis spectrophotometry, Fluorescence, Confocal and Scanning Electron Microscopy, histology etc. Work conducted during my 3rd year of PhD has been presented at the 13th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy, March 26-29, 2014, Geneva, Switzerland. For presenting my work there I got travel award from Indian Council of medical research (ICMR). Apart from this symposium, I also presented my PhD work in various national and International conferences.

Participated in the Thalassemia screening camp at Rangapur village, organized by Institute of Genetics and Hospital for Genetic Diseases, O U on 4.12.2008., Participated in a free health camp for women organized by Institute of Genetics and Hospital for Genetic Diseases, O U at the Institute Premises on 8.3.2010, Participated in the health camp organized at AP State home for Women and Children to screen women and children for general health conditions on 8.3.2010, Participated in the health camp organized at Rangapur for Zilla Parishad School children on 18.09.2010.

Epidemiology and Genetics of Stroke and its Subtypes, Pharmacogenetic Studies in Stroke; Molecular basis of Cancer; Hemoglobinopathies and Modifier genes in thalassemia

Dr. Shivalika Pathania received her B.Sc. and M.Sc. degree in Biotechnology and Bioinformatics, respectively, from Guru Nanak Dev University, Amritsar, Punjab (India). She has done Ph.D. in bioinformatics/computational biology jointly from CSIR-Institute of Himalayan Bioresource Technology, Palampur (India) and Guru Nanak Dev University, Amritsar (India) in 2017, where she studied computational systems-biological analysis of medicinal plants and utility of natural molecules in health care system through pharmacoinforamtics approach. She is currently employed as Science and Engineering Research Board-National Postdoctoral Fellow (SERB- NPDF) at Bioinformatics Centre, CSIR-Institute of Microbial Technology, Chandigarh. Her current search involves analysis of high-throughput data and development of computational approaches, which includes multi-omics data integration and applying network-biology and machine learning techniques, to predict candidate genes and pathways that regulate plant stress response and fruit ripening.

Plant Systems Biology, Computational network modeling, Multi-omics data integration, Next-generation sequencing data analysis, Machine learning, Database and prediction algorithm-development, Chemoinformatics, Structural bioinformatics

Dr Sushil Kharel has completed his MD( Doctor of Medicine) in Medical Physiology in 2014 from Kathmandu Unversity, Nepal. He is also a Medico-Legal expert with Advocate license and has done LLB( Bachelor of Law) in 2011 from Tribhuwan University, Nepal. He is presently working as a Senior Lecturer in the Department of Physiology in Nepal’s top Medical College i.e. KMCTH. He has published more than 20 papers in reputed journals, out of which 7 are of child health.

Brawijaya University-Malang : 1979-1984, Gadjah Mada University-Yogyakarta : 1993-1994, University of Padjadjaran-Bandung : 2001-2004, Brawijaya University-Malang : 2013-2016

Dr Thierry Habyarimana has completed his PhD in Molecular Oncology from Mohammed V University, Rabat, Morocco after completing a Specialized Master’s degree in Life & Health Sciences & Technologies from the same University. He is a lecturer and the Head of Department of Biomedical Laboratory Sciences at INES-Ruhengeri, an Institute of Applied Sciences in Rwanda. His research and publications are centered on Genetics and Infectious Risk Factors of Cancer and are published in reputed journals.

o Microbiology o Hematology o Clinical biochemistry o Immunoserology

Dr. Yilmaz is research geneticist at WuXi NextCODE. Before joining WuXiNextCODE, she was a postdoctoral scientist at the Neurosurgery and Genetics Departments of Yale University. With over a decade of research experience in genomic research with both biology and bioinformatics skills, Dr. Yilmaz contributed significant discoveries in the genetics of skeletal dysplasia, brain cancer, and aneurysm risks. She also has prior postdoctoral experience from King’s College London, UK where she conducted research on gene expression profiling in patients at risk for brain aneurysm. Her PhD work at the Centre Hospitalier Universitaire De Nancy, France, was focused on the genetics of Aicardi Syndrome, a rare neurological disease.

Genetics and Genomics of Common and rare diseases. Next generation sequencing, GWAS, UK Biobank, Alzheimer, Aicardi Syndrome, brain Aneurysms, vestibular schwannomas, skeletal dysplasias.

Prof. Ahmad Al-Ghamdi is a Distinguished Professor of Apiculture at Bee Research Chair, College of Agriculture, King Saud University, Riyadh, Saudi Arabia, since August 2008. He completed M. Phil. in apiculture from University of Wales, UK in 1990 and Ph.D. in Apiculture from Michigan State University, USA in 1997. He held several administrative positions in Saudi Arabia and worldwide. He is the Supervisor of the National Plan for Science, Technology & Innovation (NPST) and Engineer Abdullah Ahmad Bagshan for Bee Research, Assistant General Secretariat Arab Beekeepers’ Union, Vice President of Asian Apicultural Association and Chairman of Arab beekeepers Union. Currently he is also serving the head of several national and international committees and scientific societies. Prof. Al-Ghamdi overall apicultural research output has culminated in more than 125 publications in internationally respected journals, 112 abstracts in national and international conferences, 3 patents from European office. He is the author of 17 books. He supervised five Ph.D. and seven master students. he is the PI of several major project funded by KACST. He was awarded by Scientific Excellence at King Saud University in 2013, Excellency Rector Award of excellence in the Community Service, Lifetime Achievement Award, Taiwan, Dec. 10, 2012 and won the several gold medals in national and international conferences.

His research was pivotal in isolation and characterizations of antimicrobial agents from bee products, metagenomics, Apitherapy and molecular characterizations of Honeybee diseases using molecular tools like RNAi approach.

 Recipient of BRSI Young Scientist Award in Agricultural Biotechnology of The Biotech Research Society, Trivandrum, India 2008.  Recipient of Pran Vohra Award (2008) of Indian Science Congress Association Kolkata  Recipient of Lal Bahadur Shastri Young Scientist Award biennium (2007-08) of Indian Council of Agricultural Research (ICAR) in Crop Science, New Delhi.  Japan society for promotion of science Certificate of appreciation for contribution towards advancements in Education and Science Dialogue program, Tokyo, Japan, 2007 & 2008.  Recipient of NAAS Young Scientist’s Award biennium of the National Academy of Agricultural Sciences in Plant Protection Science, India, 2007.

Characterization of genes associated with abiotic stresses, bioinformatics and RNAi for wheat improvement, and molecular genetic variability of Pathogens, Gene silencing.

 Scientist, Head of breeding research department – Cotton research Institute. Varamin – IRAN , 2001-2007  Scientist, Deputy of research, West Azerbaijan Agricultural and Natural Resource Research Center Urmia-IRAN  Deputy Director General, West Azerbaijan Agricultural and Natural Resources Research Center, Urmia, Iran, 2014 till Now

Coordinating of 44 research projects in different parts of cotton producing areas in Iran. Introducing of new cotton cultivar named as KHORDAD by the Ministry of Agriculture of IRAN.

Dr. Ian James Martins is an Editor/Reveiwer for Open Acess Pub/Open Access Journals/MDPI journals and various other international journals. Advisory Board Member for Photon Journal. Fellow of International Agency for Standards and Ratings (IASR). Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. Chief Editor for International Journal of Diabetes Research (2014-2018), Research and Reviews: Neuroscience (2016-2018) and Journal of Diabetes and Clinical Studies (2017-2018). BIT Member (BIT Congress. Inc) with an H-index of 63, (ResearchGate (26) Scopus ID: 7103152779/Mendeley (21), UWA Research Repository (16). Scientist Science Advisory Board (USA), Academic with Academia.edu. Citations accumulated to >4551. Ian James Martins - Semantic Scholar https://www.semanticscholar.org/author/Ian-James-Martins/5258067. ResearchGate’s RG score > 96% INTERNATIONAL SCIENTISTS on www.google.com.au Ian James Martins. Certificates from Keynote addresses: Biomedicine 2018 (Osaka), Global Experts Meeting on Diabetes, Hypertension, Metabolic Syndrome 2018 (Melbourne), Laboratory Medicine 2018 (Berlin), Immunology World 2018 (Amsterdam), Innovate Pharma 2017 (Sydney), Innovate Neurology 2017, World Diabetes and Endocrinology Summit-2017 (Dubai) and Pharmacology and Ethnopharmacology 2016 (Chicago), AGHC2016 (Kaohsiung)..

Anti-Aging Genes, Food and Nutrition, Appetite, Environment, Senescence

Dr. Sukhbir Singh is Ph.D in Pharmaceutics with prosperous experience of more than 10 years in academics and research. He is highly enthused, self-determined and organized pharmaceutical research professional. Presently, the author is working as Associate Professor at Chitkara College of Pharmacy, Chitkara University, Punjab. He is also Deputy Dean of Industry Oriented Courses held in collaboration between Chitkara University and established Pharmaceutical Industries. He has 40 publications in various National/International journal of repute and filed 3 patents to his credit. He has presented/published 30 review/research abstracts in various National/International conferences. He is also engaged with 4 consultancy projects on herbal/homeopathic formulation. He is an associate editor of Open Access Journal of Pharmaceutical Research, Medwin publisher.

Nanotechnology based formulation development which includes nanospheres, nanoemulsion, solid lipid nanoparticles and liposomes; techniques for solubility enhancement of poorly soluble drugs.

Dr. Neelam is Ph.D in Pharmaceutics with affluent experience of more than 8 years in academics and research. She is highly encouraged and disciplined pharmaceutical research professional. Currently, the author is working as Associate Professor at Chitkara College of Pharmacy, Chitkara University, Punjab. She has 33 publications in various National/International journal of repute and filed 3 patents to her credit. She has presented/published 30 review/research abstracts in various National/International conferences. She is betrothed with 4 consultancy projects on herbal/homeopathic formulation.

Nanotechnology based formulation development which includes nanospheres, nanoemulsion, solid lipid nanoparticles and liposomes; Techniques for solubility enhancement of poorly soluble drugs.

❖ Ph. D. awarded from PRIST University, Thanjvur, Tamilnadu, India o Registration No. – 101110374, Date of notification- 05/01/2015 o Under the Supervision of Prof. (Dr.) A. V. Chandewar ❖ M.Pharm ( Pharmaceutics) (66%) Ist Class o 2007-2008, Sudhakarrao Naik Institute of Pharmacy, Pusad. Dist: Yavatmal, Maharashtra, India o Sant Gadge baba Amravati University, Amravati Maharashtra, India ❖ B-Pharm, (60.62%) Ist Class o 2002-2003, S. N. Institute of Pharmacy, Pusad, Dist.Yavatmal, Mahareashtra, India o Amravati University, Amravati, Maharashtra, India

❖ Osmotic drug delvery system. ❖ Worked thoroughly on oral elementary osmotic pump system. ❖ Publication of Research article on osmotic drug delvery system. ❖ Publicaton of review article on osmotic drug delvery system. ❖ Publication of online book on osmotic drug delivery system. ❖ Published book on Pharmaceutics-I & Communication Skill as per PCI Syllabus.

 Senior Lecturer in General Surgery Grigore T. Popa University of Medicine Iași (2015 - Present)  Consultant in General Surgery – St. Spiridon University Hospital Iaşi september 2008  Medical Director – Elytis Hospital (private) 2014 - December 2017  Medical Director – Sf. Spiridon University Hospital (public 1128 beds) starting January 2018

Bariatric surgery, treatment of obesity, abdominal surgery,

Mohammad Nadeem Khan received his Master degree in Biotechnology from Jiwaji University, Gwalior, India and his PhD in Pharmaceutical Biotechnology from Barkatullah University, Bhopal, India in 2014. He then moved to the University of Bastar, where he started as an Assistant Professor. He eventually held the post of Assistant Professor of the School of Studies Biotechnology.our laboratory currently focuses on the Pharmceutical and drug development .

Pharmaceutical biotechnology, naturceuticals, alternative medicine , Clinical Biochemistry and animal Plant tissue culture , bioprocess engineering , Animal cell culture , molecular Biology .Non-enzymatic glycation , prteomices , molecular docking,Bio-informatices.

Dr. Siddhartha Dutta has passed Bachelor of Medicine and Bachelor of Surgery (M.B.B.S) from Govt. Stanley Medical College, Chennai and Doctor of Medicine (M.D.) from Maulana Azad medical college, New Delhi. He has a history of working in the hospital and health care industry and has received FCCS (Fundamental Critical Care Support) certificate in Critical Care from Society of Critical Care Medicine (SCCM), California. Skilled in Pharmaceutical Care, Pharmaceutical Research, Emergency Medicine, Critical Care Medicine, Clinical Pharmacology, Clinical research and Pharmacovigilance. He also is a qualified diploma holder in Advanced Post Graduate Diploma in Clinical Research & Regulatory Affairs. His area of work involves liver cirrhosis, Spontaneous bacterial peritonitis, pharmacovigilance, preclinical research. He is currently working on metabolic disorders and metabolic syndrome. Area of interest include diabetes, cirrhosis, metabolic syndrome, endothelial dysfunction etc. Currently he is working as a Senior Resident in Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.

Personalized medicine, Metabolic disorders, Diabetes and antidiabetics, Gastroenterology, Liver cirrhosis, Pharmacovigilance, Clinical Pharmacology, Obesity, Cardiology

• Member of Local Inspection Committee from RGUHS to Vijayanagar Institute of Medical Sciences , Bellary. • Subject coordinator for Nutrition Biology course at Central Food and Technology Research Institute, Mysore. • Warden of P.G. hostel since January 2016. • Chairman of Magazine Committee for the year 2015-2016. • Subject Expert at walk in Interview at Chamaraja Institute of Medical Sciences and Kodagu Institute of Medical Sciences, Kodagu. • Member of Medical Education Unit , M.M.C.R.I, Mysore. • Member of Curriculum Committee, MMC&RI, Mysore. • Appointed as MCI inspector for Compliance verification assessment for continuance of recognition of MBBS degree granted by Saveetha University, Chennai on 18th September 2018.

Presently working with Institute of Pharmacy H.C.P.G. College, Varanasi (U.P.), INDIA as Professor formerly worked as Assistant Professor in Kanak Manjari Institute of Pharmaceutical Sciences, Rourkela (Odisha), INDIA. Expert in Analytical Chemistry and Characterization of various instrumental Techniques apart from that having prominent knowledge of phytochemicals And medicinal plants distributed in India, conducting survey of medicinal Plants and clinical survey for sanitation and hygiene.

Neurosciences,Phytochemistry,Bone disorder,Anti-Arthritic activity, Inflammation,Clinical Survey and study,Cancer research, Anti-diabetic activity